Wisdom in Gateway Laboratory Services

CLIA/CAP Gateway Laboratory Services

Rapidly bridge the gap between outsourcing and insourcing next generation sequencing testing with a comprehensive, turnkey menu of CLIA/CAP validated assays for cancer and germline testing.

Schedule Consult

Click below to learn more about each service.

Next Generation Sequencing Menu

Your tests under your brand: leverage our robust menu of CLIA/CAP validated, turnkey assays that you can begin immediately offering to your providers and patients.

Flexible Insourcing Options

Under the CAP Distributive Model of Next Generation Sequencing Testing, our Laboratory Services offerings enable you to choose which components to insource for more rapid deployment of genomic testing in your institution.

Next Generation Sequencing Test Menu

Somatic Cancer Testing - Hybrid Capture

Somatic Cancer Testing - Ampliseq-Based

Hereditary/Germline Testing

Schedule Consult

Flexible Insourcing Options

Above is a graphic of the next generation sequencing testing workflow. The CAP Distributive Model of Next Generation Sequencing Testing enables any CLIA/CAP lab to outsource individual components to one or more additional CLIA/CAP labs.

Advantages of the CAP Distributive Model for Next Generation Sequencing Testing

Lowers Risks and Costs

Begin insourcing genomic testing immediately without the upfront validation expenditures and while capital budgets are still being approved.

Rapid Learning

Develop core competencies and stronger collaboration with your clinical providers to better evaluate ordering patterns and learn which assays have the highest utility.

Controls Data Access

Access all raw and processed genomic data in discrete formats to begin building your repository of diagnostic validation samples and to facilitate subsequent serial testing for your patients.

Schedule Consult

Resources

Shalini Verma MD, FCAP

Meet our Medical and Laboratory Director

Shalini Verma, MD, FCAP

Read Blog Post →
Interpretation and Reporting of Sequence Variants in Cancer

Webinar: Interpretation and Reporting of Sequence Variants in Cancer

A practiced based guide.

Access Webinar →
CAP Distributive Model of Next Generation Sequencing Testing

CAP Distributive Model of NGS Testing

A rapid, economical approach to building your clinical next generation sequencing testing program.

Access Webinar →

Trusted by leading cancer centers, medical centers, health systems and reference laboratories.

Moffit_gray
University-of-Vermont_gray
WashU_gray
Cedars_gray
Northwestern_Medicine_gray
Adventist_gray
Northshore_gray
Atrium_gray
Dartmouth_gray
Cleveland-Clinic_gray
Seattle-Childrens_gray
HLI_gray
Tricore_gray
St-Lukes_gray
Augusta-University_gray
UAB_gray
alpha-genomix_gray
University-of-Maryland_gray
Nicklaus-Childrens_gray
Wake-Forest_gray
George-Washington-University_gray
Health-Network-Laboratories_gray
Hackensack_gray
University-of-Virginia_gray
University-of-New-Mexico_gray
Wisdom-in-Lab-Services_1920x1216

“Working with PierianDx has been an ideal partnership. They have been with us since the early onset of our program, providing both the technology and services that allowed us to ramp our program much faster.”

- Anthony Magliocco, MD - Chair, Anatomic Pathology, Moffitt Cancer Center

Moffit_white

"I knew that with the resources we had, there was no way to create something that would rival a system like the CGW. As we've set up reflex testing in various cancer types, we have been well supported to scale the massive undertaking..."

- Nikoletta Sidiropoulos, MD - Medical Director, University of Vermont Medical Center

University-of-Vermont_white

 

“There's going to be a bottleneck in the professional component as well sometimes. PierianDx allowed us to widen that bottleneck and to have more uniformity of reporting.”

- Eric Loo, MD - Asst. Professor, Pathology and Lab Medicine, Dartmouth-Hitchcock

Dartmouth_white

“We chose PierianDx because their technology combined with expert scientific and clinical services will help accelerate TriCore’s ability to expand our NGS test offerings and provide enhanced clinically actionable information.

- Eric Carbonneau - Director Core Laboratory Operations, TriCore Reference Laboratories

Tricore_white

“A new partnership with PierianDx expands our reporting to include current clinical trials and up-to- the-minute treatment options, all linked to NorthShore’s Electronic Medical Record.”

- NorthShore University HealthSystem Kellogg Cancer Center 2017 Annual Report

Northshore_white

Learn how we can help you rapidly and economically build your in-house clinical genomics testing menu.

Schedule Consult